Nevro Corp. (NVRO)
USD 5.84
(0.0%)
USD 5.84
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 118.67 Million USD | 19.11% |
| 2022 | 99.63 Million USD | 6.55% |
| 2021 | 93.51 Million USD | 12.27% |
| 2020 | 83.29 Million USD | -9.04% |
| 2019 | 91.57 Million USD | -0.5% |
| 2018 | 92.03 Million USD | -6.2% |
| 2017 | 98.11 Million USD | 15.13% |
| 2016 | 85.22 Million USD | 36.51% |
| 2015 | 62.43 Million USD | 320.23% |
| 2014 | 14.85 Million USD | 46.75% |
| 2013 | 10.12 Million USD | 5.57% |
| 2012 | 9.58 Million USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 120.78 Million USD | 1.78% |
| 2024 Q2 | 126.09 Million USD | 4.39% |
| 2023 Q1 | 113.29 Million USD | 13.7% |
| 2023 FY | 118.67 Million USD | 19.11% |
| 2023 Q3 | 122.42 Million USD | 1.94% |
| 2023 Q2 | 120.08 Million USD | 6.0% |
| 2023 Q4 | 118.67 Million USD | -3.06% |
| 2022 Q1 | 90.58 Million USD | -3.13% |
| 2022 Q2 | 93.52 Million USD | 3.24% |
| 2022 Q3 | 98.52 Million USD | 5.35% |
| 2022 Q4 | 99.63 Million USD | 1.13% |
| 2022 FY | 99.63 Million USD | 6.55% |
| 2021 Q2 | 85.72 Million USD | -0.1% |
| 2021 Q3 | 91.8 Million USD | 7.08% |
| 2021 Q4 | 93.51 Million USD | 1.87% |
| 2021 Q1 | 85.81 Million USD | 3.02% |
| 2021 FY | 93.51 Million USD | 12.27% |
| 2020 FY | 83.29 Million USD | -9.04% |
| 2020 Q3 | 84.14 Million USD | -8.38% |
| 2020 Q1 | 92.98 Million USD | 1.53% |
| 2020 Q4 | 83.29 Million USD | -1.01% |
| 2020 Q2 | 91.84 Million USD | -1.22% |
| 2019 FY | 91.57 Million USD | -0.5% |
| 2019 Q2 | 92.35 Million USD | -0.84% |
| 2019 Q3 | 90.73 Million USD | -1.76% |
| 2019 Q1 | 93.14 Million USD | 1.2% |
| 2019 Q4 | 91.57 Million USD | 0.94% |
| 2018 Q1 | 97.49 Million USD | -0.63% |
| 2018 Q3 | 93.6 Million USD | -1.46% |
| 2018 Q4 | 92.03 Million USD | -1.68% |
| 2018 FY | 92.03 Million USD | -6.2% |
| 2018 Q2 | 94.99 Million USD | -2.57% |
| 2017 Q2 | 87.01 Million USD | 2.69% |
| 2017 FY | 98.11 Million USD | 15.13% |
| 2017 Q4 | 98.11 Million USD | 2.66% |
| 2017 Q3 | 95.57 Million USD | 9.84% |
| 2017 Q1 | 84.73 Million USD | -0.57% |
| 2016 Q4 | 85.22 Million USD | 16.16% |
| 2016 Q1 | 67.57 Million USD | 8.24% |
| 2016 FY | 85.22 Million USD | 36.51% |
| 2016 Q2 | 68.12 Million USD | 0.81% |
| 2016 Q3 | 73.36 Million USD | 7.7% |
| 2015 Q1 | 18.23 Million USD | 22.75% |
| 2015 FY | 62.43 Million USD | 320.23% |
| 2015 Q2 | 26.37 Million USD | 44.61% |
| 2015 Q4 | 62.43 Million USD | 46.37% |
| 2015 Q3 | 42.65 Million USD | 61.73% |
| 2014 Q2 | 11.64 Million USD | 15.43% |
| 2014 Q1 | 10.09 Million USD | -0.32% |
| 2014 Q3 | 12.12 Million USD | 4.09% |
| 2014 Q4 | 14.85 Million USD | 22.53% |
| 2014 FY | 14.85 Million USD | 46.75% |
| 2013 FY | 10.12 Million USD | 5.57% |
| 2013 Q4 | 10.12 Million USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2012 FY | 9.58 Million USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Abbott Laboratories | 6.57 Billion USD | 98.194% |
| Allurion Technologies Inc. | 6.17 Million USD | -1823.124% |
| Artivion, Inc. | 81.97 Million USD | -44.769% |
| Avanos Medical, Inc. | 163.2 Million USD | 27.282% |
| Butterfly Network, Inc. | 75.83 Million USD | -56.488% |
| Butterfly Network, Inc. | 75.83 Million USD | -56.488% |
| Bio-Rad Laboratories, Inc. | 780.51 Million USD | 84.795% |
| Boston Scientific Corporation | 2.48 Billion USD | 95.222% |
| CONMED Corporation | 318.32 Million USD | 62.718% |
| Edwards Lifesciences Corporation | 1.16 Billion USD | 89.841% |
| Paragon 28, Inc. | 98.06 Million USD | -21.021% |
| Glaukos Corporation | 41.98 Million USD | -182.656% |
| Globus Medical, Inc. | 848.13 Million USD | 86.007% |
| Inspire Medical Systems, Inc. | 33.88 Million USD | -250.232% |
| Integer Holdings Corporation | 239.71 Million USD | 50.493% |
| Medtronic plc | 5.21 Billion USD | 97.725% |
| Myomo, Inc. | 1.8 Million USD | -6480.291% |
| Owlet, Inc. | 6.49 Million USD | -1727.753% |
| Penumbra, Inc. | 388.02 Million USD | 69.415% |
| Vicarious Surgical Inc. | - USD | -Infinity% |
| Smith & Nephew plc | 2.39 Billion USD | 95.045% |
| Sonendo, Inc. | 11.07 Million USD | -971.663% |
| STERIS plc | 674.53 Million USD | 82.406% |
| Stryker Corporation | 4.84 Billion USD | 97.55% |
| Vapotherm, Inc. | 22.96 Million USD | -416.701% |
| Zimmer Biomet Holdings, Inc. | 2.38 Billion USD | 95.024% |